BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NPAC-AIIPC - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://npac-aiipc.org
X-WR-CALDESC:Events for NPAC-AIIPC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230420T000000
DTEND;TZID=America/Toronto:20230422T235959
DTSTAMP:20260607T010201
CREATED:20230115T183139Z
LAST-MODIFIED:20230115T185114Z
UID:2425-1681948800-1682207999@npac-aiipc.org
SUMMARY:5th Annual BC Substance Use Conference THE CHALLENGE OF CHANGE
DESCRIPTION:The Challenge of Change\n\n\n\nThe BCCSU conference planning committee is excited to announce that the 5th annual BC Substance Use Conference will be held April 20–22\, 2023.   \n\n\n\nTo enable provincial-wide participation\, we will be hosting a blended conference this year\, with both virtual and in-person options for attendance. The in-person program will be held at the JW Marriott Parq Vancouver.   \n\n\n\nThe conference theme this year is The Challenge of Change. We hope this theme will empower conference attendees to better understand and adapt to the rapidly changing landscape within which we live and work. \n\n\n\n \n\n\n\nCheck out the BC Centre for Substance Use website for details: https://www.bccsu.ca/bc-substance-use-conference/
URL:https://npac-aiipc.org/event/5th-annual-bc-substance-use-conferencethe-challenge-of-change/
CATEGORIES:Annual Conferences
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230422T081500
DTEND;TZID=America/Toronto:20230422T161500
DTSTAMP:20260607T010201
CREATED:20230414T024753Z
LAST-MODIFIED:20230414T024757Z
UID:2576-1682151300-1682180100@npac-aiipc.org
SUMMARY:2023 Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines
DESCRIPTION:Dr. Yesne Alici welcomes you to the 2023 Psychopharmacology in Cancer Care virtual course. \n\n\n\nClinicians have numerous tools at their disposal to help adult cancer patients dealing with symptoms of depression\, anxiety\, and other cancer sequelae. Psychiatric medications are most frequently prescribed to cancer patients by oncologists and general practitioners\, however\, psychiatric syndromes are often underdiagnosed and undertreated. Few oncology practices have dedicated psychiatric consultants familiar with the nuances of Psycho-Oncology. Even when patients receive psychotropic medications appropriately\, they may have problems that arise before their next oncology visit or before they see the person who prescribed their psychiatric medications. Psychologists\, nurses\, and social workers play an essential role in identifying psychological and physical symptoms as well as both beneficial and problematic medication effects as they provide frontline psychosocial interventions and support for cancer patients.  \n\n\n\nThis course is designed for the non-prescribing psycho-oncology clinician as well as the psychiatrist who is new to the world of Psycho-pharmaco-oncology. Oncologists\, palliative care clinicians\, advanced practice nurses\, and oncology nurses will find this course useful as well. The course will focus on key target disorders and symptoms amenable to psychopharmacological intervention\, including anxiety\, depression\, delirium\, sleep disturbance\, pain\, fatigue\, and weight and appetite loss. The course will also include updates on COVID-19-related delirium and the use of novel interventions including ketamine\, medical marijuana\, and psilocybin for depression\, anxiety\, and pain. Participants will learn to identify psychological reactions to medical conditions or treatments; psychiatric presentations of medical conditions or treatments; medical presentations of psychiatric conditions and common medical complications of psychiatric conditions or treatments.  \n\n\n\nBasic information will be presented about medications used to alleviate Quality of Life symptoms that arise in cancer setting from diagnosis to survivorship or end-of-life care\, and the interface of psychotherapy and medication management. We will review why certain medications are used and why some are avoided\, looking at potential benefits\, unwanted side effects\, and drug-drug interactions\, since you may be the first person to identify a serious adverse event. The course will also enhance your ability to provide psychoeducation to patients regarding psychiatric medications. \n\n\n\nThis course is co-sponsored by the MSK Psycho-Oncology Education and Training Institute (POETI). \n\n\n\nWho Should Attend \n\n\n\nThis course is intended for Psychiatrists\, Psycho-oncologists\, Oncologists\, Palliative Care Physicians\, Physician Assistants\, Nurse Practitioners\, Nurses\, Psychologists\, Social Workers and Counselors. \n\n\n\n2023 Program Highlights \n\n\n\nThis year’s program includes topics on: \n\n\n\n\nDepressive Disorders (Andrew Roth\, MD)\n\n\n\nDelirium (William Breitbart\, MD)\n\n\n\nAnxiety Disorders (Andrew Roth\, MD)\n\n\n\nSleep Disorders (Yesne Alici\, MD)\n\n\n\nCancer-Related Fatigue (William Breitbart\, MD)\n\n\n\nPain (Natalie Moryl\, MD)\n\n\n\nWeight and Appetite Loss (Yesne Alici\, MD)\n\n\n\nCancer and Cancer-Treatment Related Cognitive Changes (Yesne Alici\, MD)\n\n\n\nNovel Psychopharmacologic Interventions in Oncology (Christian Bjerre Real\, MD\, MMCI\, FAPA)\n\n\n\n\nAdditionally\, there will be ample time during program breaks to meet the faculty and ask questions. View the course brochure. \n\n\n\nObjectives \n\n\n\n\nDescribe basic psycho-pharmaco-oncology principles for understanding and treating anxiety\, depression and delirium in people with cancer.\n\n\n\nDiscuss basic psycho-pharmaco-oncology principles for understanding and improving quality of life and psychiatric palliative care in people with cancer\, including managing cognitive changes\, insomnia\, fatigue\, poor appetite and weight loss\, and pain.\n\n\n\nIdentify the nuances of psycho-pharmaco-oncology related to COVID-19 related delirium and the use of novel interventions including ketamine\, medical marijuana\, and psilocybin for depression\, anxiety\, and pain in people with cancer.\n\n\n\n\nRegistration \n\n\n\nRegistration Fees \n\n\n\n\nPhysicians (MD\, DO\, MBBS\, or equivalent): $150\n\n\n\nResidents\, Fellows\, Advanced Practice Providers\, Nurses\, Psychologists\, Social Workers\, Counselors\, and Other Healthcare Providers: $100\n\n\n\nIndustry Professionals*: $262.50\n\n\n\nMSK Employees: Complimentary\n\n\n\n\nA registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend this course. If you are a member of one of these groups\, contact cme@mskcc.org for details. Please note that after your payment has been processed\, no further promotional discounts or adjustments will be made to your registration. \n\n\n\n*Industry professionals may attend MSK CME activities for their own education. Marketing\, sales\, and promotion of products and services is strictly prohibited at MSK CME activities. For more information\, please visit our Help page. \n\n\n\nVirtual Registration \n\n\n\nThis live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). Access details\, including a link to Zoom and faculty disclosures\, will be emailed to registrants prior to the start of the course. \n\n\n\nCancellation Policy \n\n\n\nIf you wish to cancel your participation in this course\, you must email cme@mskcc.org at least seven (7) days prior to the start of the course\, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed\, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting cme@mskcc.org with the appropriate information.  \n\n\n\nMSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course\, you will be notified via email from MSK CME (cme@mskcc.org). A full refund will be issued for your registration. MSK CME is not responsible for any related costs\, charges\, or expenses to participants\, including fees incurred by airline/travel/lodging agencies. \n\n\n\nAccreditation \n\n\n\nMemorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. \n\n\n\nAMA Credit Designation Statement \n\n\n\nMemorial Sloan Kettering Cancer Center designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \n\n\n\nANCC CNE Statement \n\n\n\nMemorial Sloan Kettering Cancer Center–Nursing Professional Development / Continuing Education is accredited with distinction as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center’s Commission on Accreditation. \n\n\n\n6.75 contact hours will be awarded to participants who attend the program in its entirety and complete a program evaluation. Partial credit not awarded.  \n\n\n\nSocial Work Accreditation Statement* \n\n\n\nThis presentation is approved for a maximum of 6.50 Continuing Education Contact Hours of Live Virtual Training. Memorial Sloan Kettering Cancer Center is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0228. \n\n\n\nContinuing Education for Licensed Psychologists in New York State** \n\n\n\nThis event offers 6.75 NYS Psychology Contact Hours. \n\n\n\nMemorial Sloan Kettering Cancer Center is recognized by the New York State Education Department State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0166
URL:https://npac-aiipc.org/event/2023-psychopharmacology-in-cancer-care-an-update-for-clinicians-of-all-disciplines/
END:VEVENT
END:VCALENDAR